Elixir Medical Corporation

Elixir Medical Corporation is a medical technology company based in Milpitas, California, dedicated to innovating treatments for coronary and peripheral artery disease. Founded by Motasim Sirhan, the company focuses on developing advanced platforms that not only open clogged arteries but also restore natural vessel function and physiology. The flagship product, the DynamX® Coronary Bioadaptor System, is designed to enhance blood flow while allowing the artery to move naturally, promoting better vessel health compared to traditional stents. Elixir Medical also works on platforms for peripheral artery disease and is involved in the development and clinical trials of novel devices, including plans for regulatory approvals in the U.S. and Japan. The company aims to improve long-term outcomes for patients suffering from heart and vascular diseases, particularly those undergoing percutaneous coronary intervention (PCI). Elixir Medical is committed to transforming cardiovascular care by focusing on restoring natural vessel physiology, helping patients achieve better health and quality of life.

• Employees 110
• Founded 2005
• Annual Revenue $7800000
• Total Funding $5299700